Vectura Group plc Share Consolidation and Total Voting Rights (7007P)
14 Ottobre 2019 - 08:00AM
UK Regulatory
TIDMVEC
RNS Number : 7007P
Vectura Group plc
14 October 2019
Share Consolidation and Total Voting Rights
Chippenham, UK - 14 October 2019: Vectura Group plc (LSE: VEC)
("Vectura" or "the Company") announces that the Share Consolidation
by which every 13 Existing Ordinary Shares of GBP0.00025 each will
be consolidated into 12 New Ordinary Shares of GBP0.000271 each
will take effect from 8.00 a.m. (London time) today (or as soon as
practicable thereafter) ("Admission"). At that time, 615,305,592
New Ordinary Shares of GBP0.000271 each (under ISIN: GB00BKM2MW97)
will be admitted to the premium listing segment of the Official
List and to trading on the London Stock Exchange's main market for
listed securities.
Each shareholder's percentage holding in the total issued share
capital of the Company immediately before and after the
implementation of the Share Consolidation will (save in respect of
fractional entitlements) remain unchanged. The New Ordinary Shares
will have the same rights, including voting and dividend rights, as
the Existing Ordinary Shares.
With effect from Admission, share certificates in respect of the
Existing Ordinary Shares will cease to be valid and it is expected
that share certificates in respect of the New Ordinary Shares will
be dispatched on 25 October 2019 to shareholders who hold their
shares in certificated form. Shareholders who held their Existing
Ordinary Shares in CREST will have the New Ordinary Shares to which
they are entitled automatically credited to their CREST accounts at
approximately 8.00 a.m. (London time) today (or as soon as
practicable thereafter).
Vectura confirms that the shares currently held by its directors
and their connected persons will also be consolidated with effect
from Admission, but that their relevant percentage interests
following consolidation will remain the same as those prior to
consolidation (subject to any fractional entitlements resulting
from the Share Consolidation). Their expected interests in the New
Ordinary Shares in the Company following consolidation will be as
follows:
Name Director/PDMR Number of New Ordinary
Shares following Consolidation
Bruno Angelici Chairman 219,602
------------------------ --------------------------------
Per-Olof Andersson Non-Executive Director 46,153
------------------------ --------------------------------
Neil Warner Non-Executive Director 28,132
------------------------ --------------------------------
Thomas Werner Non-Executive Director 114,776
------------------------ --------------------------------
Juliet Thompson Non-Executive Director 45,261
------------------------ --------------------------------
Total Voting Rights
As at close of business on 11 October 2019, the Company's issued
share capital consisted of 666,581,058 Existing Ordinary Shares of
GBP0.00025, each of which had one voting right. The Company does
not hold any shares in treasury. Following the Share Consolidation,
the Company's issued share capital will consist of 615,305,592 New
Ordinary Shares of GBP0.000271 each, each of which will have one
voting right. This figure of 615,305,592 may be used by
shareholders as the denominator for the calculations by which they
determine if they are required to notify their interest in, or a
change to their interest in, New Ordinary Shares under the FCA's
Disclosure Guidance and Transparency Rules.
- Ends-
Definitions
"Admission" means the admission of the New Ordinary Shares (i)
to the premium segment of the Official list of the United Kingdom
Listing Authority and (ii) to trading on the Main Market becoming
effective, in accordance with, respectively, the Listing Rules and
the Admission and Disclosure Standards;
"CREST" means the relevant system (as defined in the
Uncertificated Securities Regulations 2001 (as amended)) in respect
of which CRESTCo UK & Ireland Limited is the operator (as
defined in the Uncertificated Securities Regulations 2001 (as
amended));
"Existing Ordinary Shares" means the ordinary shares of
GBP0.00025 each in the capital of the Company prior to the Share
Consolidation;
"FCA" means the United Kingdom's Financial Conduct Authority (or
any successor body in respect thereof);
"Listing Rules" means the Listing Rules of the FCA made for the
purposes of Part VI of the Financial Services and Markets Act 2000,
as amended;
"Main Market" means the London Stock Exchange plc's main market
for listed securities;
"New Ordinary Shares" means the ordinary shares of GBP0.000271
each in the capital of the Company resulting from the Share
Consolidation; and
"Share Consolidation" means the consolidation of every 13
Existing Ordinary Shares into 12 New Ordinary Shares.
For more information, please contact:
Vectura Group plc +44 (0)1249 667700
John Murphy Company Secretary
Consilium Strategic Communications +44 (0)20 3709 5700
Mary-Jane Elliott / Sue Stuart / David Daley
About Vectura
Vectura is a provider of innovative inhaled drug delivery
solutions that enable partners to bring their medicines to
patients. With differentiated proprietary technology and
pharmaceutical development expertise, Vectura is one of the few
companies globally with the device, formulation and development
capabilities to deliver a broad range of complex inhaled
therapies.
Vectura has ten key inhaled and eleven non-inhaled products
marketed by partners with global royalty streams, and a diverse
partnered portfolio of drugs in clinical development. Our partners
include Hikma, Novartis, Sandoz (a division of Novartis AG),
Mundipharma, Kyorin, GSK, Bayer, Chiesi, Almirall, and Tianjin
KingYork.
For further information, please visit Vectura's website at
www.vectura.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCMJBLTMBBBBLL
(END) Dow Jones Newswires
October 14, 2019 02:00 ET (06:00 GMT)
Grafico Azioni Vectura (LSE:VEC)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Vectura (LSE:VEC)
Storico
Da Mar 2023 a Mar 2024